Immunogold study of effects of prenatal exposure to lipopolysaccharide and/or valproic acid on the rat blood-brain barrier vessels

Journal of Neurocytology

Volumn 34, Issue 6, 2006, Pages 435-446

  Vorbrodt, A W ^a   Dobrogowska, D H ^a   Kozlowski, P B ^a   Rabe, A ^a   Tarnawski, M ^a,b   Lee, M H ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLUCOSE TRANSPORTER 1; LIPOPOLYSACCHARIDE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN DAMAGE; BRAIN REGION; CELL MEMBRANE; CELL POLARITY; CELL ULTRASTRUCTURE; CEREBELLUM; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; FEMALE; GLUCOSE TRANSPORT; HIPPOCAMPUS; IMMUNOGOLD LABELING; MORPHOMETRICS; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TRANSCYTOSIS;

ALBUMINS; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CELL MEMBRANE; CEREBRAL ARTERIES; CHILD; DEVELOPMENTAL DISABILITIES; DRUG SYNERGISM; ENDOCYTOSIS; ENDOTHELIAL CELLS; ENZYME INHIBITORS; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MENTAL RETARDATION; MICROCIRCULATION; MICROSCOPY, ELECTRON, TRANSMISSION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, LONG-EVANS; VALPROIC ACID;

EID: 33747448092     PISSN: 03004864     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11068-006-8729-x     Document Type: Article

References (44)

1. ALLEN, G. & COURCHESNE, E. (2003) Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism. American Journal of Psychiatry 160, 262-273.
2. BANKS, W. A., KASTIN, A. J., BRENNAN, J. M. & VALLANCE, K. L. (2003) Absorptive endocytosis of HIV-1 gp120 by blood-brain barrier is enhanced by lipopolysaccharide. Experimental Neurology 156, 165-171.
3. BOLZ, S., FARRELL, C. L., DIETZ, K & WOLBURG, H. (1996) Subcellular distribution of glucose transporter (GLUT-1) during development of the blood-brain barrier in rats. Cell and Tissue Research 284, 355-365.
4. CORNFORD, E. M., HYMAN, S. & PARDRIDGE, W. M. (1993) An electron microscopic immunogold analysis of developmental up-regulation of the blood-brain barrier Glut1 glucose transporter. Journal of Cerebral Blood Flow and Metabolism 13, 841-854.
5. CHRISTIANSON, A. L., CHESLER, N. & KROMBERG, J. G. (1994) Fetal valproate syndrome: clinical and neurodevelopmental features in two sibling pairs. Developmental Medicine and Child Neurology 36, 361-369.
6. DERMIETZEL, R., KRAUSE, D., KREMER, M., WANG, C. & STEVENSON, B. (1992) Pattern of glucose transporter (Glut1) expression in embryonic brains is related to maturation of blood-brain barrier tightness. Developmental Biology 193, 152-163.
7. DE VIVO, D. C., TRIFILETTI, R., JACOBSON, R. I. & HARIK, S. I. (1990) Glucose transporter deficiency causing persistent hypoglycorrhachia: A unique cause of infantile seizures and acquired microcephaly. Annals of Neurology 28, 414-415.
8. DOBROGOWSKA, D. H. & VORBRODT, A. W. (1999) Quantitative immunocytochemical study of blood-brain barrier glucose transporter (Glut-1) in four regions of mouse brain. Journal of Histochemistry and Cytochemistry 47, 1021-1029.
9. DREWES, L. R. (1998) Biology of the blood-brain glucose transporter. In Introduction to the Blood-Brain Barrier (edited by Pardridge, W. M.) pp. 165-174. Cambridge: Cambridge University Press.
10. EL-KHODOR, B., KOZLOWSKI, P. B., RABE, A. & LEE, M. H. (2003) Prenatal valproic acid and lipopolysaccharide synergistically produce behavioral and neuroanatomical changes. Developmental Psychobiology 43, 253.
11. ENGELHARDT, B. & RISAU, W. (1995) Development of the blood-brain barrier. In new concepts of a blood-brain barrier (edited by Greenwood, J., Begley, D.J. & Segal, M.B.) pp.11-31. New York and London: Plenum Press.
12. FARRELL, C. L. & PARDRIDGE, W. M. (1991) Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial luminal and abluminal membranes: An electron microscopic immunogold study. Proceedings of the National Academy of Sciences USA 88, 5779-5783.
13. FATEMI, S. H., EARLE, J., KANODIA, R., KIST, D., EMAMIAN, E. S., PATTERSON, P.H., SHI, L.M. & SIDWELL, R. (2002) Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: Implications for genesis of autism and schizophrenia. Cellular and Molecular Neurobiology 22, 25-33.
14. GIBBS, J. P., ADEYEYE, M. C., YANG, Z. & SHEN, D. D. (2004) Valproic acid uptake by bovine brain microvessel endothelial cells: role of active transport. Epilepsy Research 58, 53-66.
15. GORDON, N. & NEWTON, R. W. (2003) Glucose transporter type 1 (GLUT-1) deficiency. Brain Development 25, 477-480.
16. HORNIG, M., WEISSENBOCK, H., HORSCROFT, N. & LIPKIN WI (1999) An infection-based model of neurodevelopmental damage. Proceedings of the National Academy of Sciences USA 96, 12102-12107.
17. HORNIG, M. & LIPKIN, W. I. (2001) Infectious and immune factors in the pathogenesis of neurodevelopmental disorders: Epidemiology, hypotheses, and animal models. Mental Retardation and Developmental Disability Research Review 7, 200-210.
18. INGRAM, J. L., PECKHAM, S. M., TISDALE, B. & RODIER, P. M. (2000) Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicology and Teratology 22, 319-324.
19. KAUFMANN, W. E., COOPER, K. L., MOSTOFSKY, S. H., CAPONE, G. T., KATES, W. R., NEWSCHAFFER, C. J., BUKELIS, I., STUMP, M. H., JANN, A. E. & LANHAM, D. C. (2003) Specificity of cerebellar vermian abnormalities in autism: A quantitative magnetic resonance imaging study. Journal of Children Neurology 18, 463-470.
20. LIPPOLDT, A., KNIESEL, U., LIEBNER, S., KALBACHER, H., KIRSCH, T., WOLBURG, H. & HALLER, H. (2000) Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood-brain barrier endothelial cells. Brain Research 885, 251-261.
21. MCILVANE, W. J. & CATALDO, M. F. (1996) On the clinical relevance of animal models for the study of human mental retardation. Mental Retardation and Developmental Disability Research Review 2, 188-196.
22. MURATORI, F., CESARI, A. & CASELLA, C. (2001) Autism and cerebellum. An unusual finding with MRI. Panminerva Medicine 43, 311-315.
23. OMTZIGT, J. G., NAU, H., LOS, F. J., PIJPERS, L. & LINDHOUT, D. (1992) The disposition of valproate and its metabolites in the late first trimester and early second trimester of pregnancy in maternal serum, urine, and amniotic fluid: Effect of dose, co-medication, and the presence of spina bifida. European Journal of Clinical Pharmacology 43, 381-388.
24. PASCUAL, J.M., VAN HEERTUM, R.L., WANG, D., ENGELSTAD, K. & DE VIVO, D.C. (2002) Imaging the metabolic footprint of Glut 1 deficiency on the brain. Annals of Neurology 52, 458-464.
25. PLETNIKOV, M. V., MORAN, T. H. & CARBONE, K. M. (2002) Borna disease virus infection of the neonatal rat: Developmental brain injury model of autism spectrum disorders. Frontiers of Biosciences 7, D593-D607.
26. SCHNEIDER, M. L., MOORE, C. F. & KRAEMER, G. W. (2001a) Moderate alcohol during pregnancy: Learning and behavior in adolescent rhesus monkeys. Alcohol Clinical and Experimental Research 25, 1383-1392.
27. SCHNEIDER, T., LABUZ, D. & PRZEWLOCKI, R. (2001b) Nociceptive changes in rats after prenatal exposure to valproic acid. Polish Journal of Pharmacology 53, 531-534.
28. SOBANIEC-LOTOWSKA, M. E. & SOBANIEC, W. (1996) Morphological features of encephalopathy after chronic administration of the antiepileptic drug valproate to rats. A transmission electron microscopic study of capillaries in the cerebellar cortex. Experimental Toxicology and Pathology 48, 65-75.
29. TARNAWSKI, J., WEN, G.Y., HEANEY, A., MA, S., EL-KHODOR, B.F., RABE, A., KOZLOWSKI, P.B. & LEE, M.H. (2004) Combined exposure to lipopolysaccharide and valproic acid during early embryonic development in rats. Program No. 359.12. Society for Neuroscience Abstracts Viever/Itinerary Planner, Washington DC.
30. TEMESVÁRI, P., ÁBRAHÁM, C. S., SPEER, C. P., KOVÁCS, J. & MEGYERI, P. (1993) Escherichia coli 0111 B4 lipopolysaccharide given intracisternally induces blood-brain barrier opening during experimental neonatal meningitis in piglets. Pediatric Research 34, 182-186.
31. VESZELKA, S., URBÁNYI, Z., PÁZMÁNY, T., NÉMETH, L., OBÁL, I., DUNG, N.T.K., ÁBRAHÁM, C.S., SZABÓ, G. & DELI, M.A. (2003) Human serum amyloid component attenuates the bacterial lipopolysaccharide-induced increase in blood-brain barrier permeability in mice. Neuroscience Letters 352, 57-60.
32. VORBRODT, A. W. (1993). Morphological evidence of the functional polarization of brain microvascular endothelium. In The Blood-Brain Barrier (edited by Pardridge, W.M.) pp. 137-164. New York: Raven Press.
33. VORBRODT, A. W. (1995) The application of quantitative immunocytochemistry for the evaluation of blood-brain barrier (BBB) to endogenous albumin. In New Concepts of a Blood-Brain Barrier (edited by Greenwood, J., Begley,, D.J. & Segal, M. B.) pp. 39-46. New York and London: Plenum Press.
34. VORBRODT, A. W. & DOBROGOWSKA, D. H. (1994) Immunocytochemical evaluation of blood-brain barrier to endogenous albumin in adult, newborn and aged mice. Folia Hictochemica et Cytobiologica 32, 63-70.
35. VORBRODT, A. W., DOBROGOWSKA, D. H., TARNAWSKI, M. & LOSSINSKY, A. S. (1994) A quantitative immunocytochemical study of the osmotic opening of the blood-brain barrier to endogenous albumin. Journal of Neurocytology 23, 792-800.
36. VORBRODT, A. W., DOBROGOWSKA, D. H., UENO, M. & LOSSINSKY, A.S. (1995) Immunocytochemical studies of protamine-induced blood-brain barrier opening to endogenous albumin. Acta Neuropathologica 89, 491-499.
37. VORBRODT, A. W., DOBROGOWSKA, D. H., TARNAWSKI, M., MEEKER, H. C. & CARP, R. I. (1997) Immunocytochemical evaluation of blood-brain barrier to endogenous albumin in scrapie-infected mice. Acta Neuropathologica 93, 341- 348.
38. VORBRODT, A. W., DOBROGOWSKA, D. H., MEEKER, H. C. & CARP, R. I. (1999) Immunogold study of regional differences in the distribution of glucose transporter (GLUT-1) in mouse brain associated with physiological and accelerated aging and scrapie infection. Journal of Neurocytology 28, 711-719.
39. VORBRODT, A. W., DOBROGOWSKA, D. H., KOZLOWSKI, P., TARNAWSKI, M., DUMAS, R. & RABE, A. (2001a) Effect of a single embryonic exposure to alcohol on glucose transporter (Glut-1) distribution in brain vessels of aged mouse. Journal of Neurocytology 30, 167-174.
40. VORBRODT, A. W., DOBROGOWSKA, D. H., TARNAWSKI, M., MEEKER, H. C. & CARP, R. I. (2001b) Quantitative immunogold study of glucose transporter (GLUT-1) in five brain regions of scrapie-infected mice showing obesity and reduced glucose tolerance. Acta Neuropathologica 102, 278-284.
41. VORHEES, C. V., WEISENBURGER, W. P. & MINCK, D. R. (2001) Neurobehavioral teratogenic effects of thalidomide in rats. Neurotoxicology and Teratology 23, 255-264.
42. WILLIAMS, G., KING, J., CUNNINGHAM, M., STEPHAN, M., KERR, B. & HERSH, J.H. (2001) Fetal valproate syndrome and autism: Additional evidence of an association. Developmental Medicine and Children Neurology 43, 202-206.
43. XAIO, H., BANKS, W.A., NIEHOFF, M.L. & MORLEY, J.E. (2001) Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Research 896, 36-42.
44. XIA, M., WANG, D., PASCUAL, J. M., YANG, H., STINER, S. & DE VIVO, D. C. (2004) Effects of valproic acid on Glut-1 gene expression. Program No. 197.9 Society of Neuroscience Abstract Viewer/Itinerary Planner. Washington, DC.